MERGE EFILM AND TPS MEDICAL EXPAND RELATIONSHIP TO BRING INNOVATIVE PACS, WEB AND IMAGE DISTRIBUTION SOLUTION THROUGHOUT THE UK - Global organization with broad understanding of UK healthcare PACS market to localize delivery, service and support.

Milwaukee, WI, July 1, 2003 - Merge eFilm (Nasdaq: MRGE), a leading global radiology software and services company, and TPS Medical, a UK-based healthcare solutions provider, today announced that they are expanding their PACS, Teleradiology and Web solution, with local service and support, throughout the UK healthcare market.

"The UK healthcare market has unique needs that require cost-effective image management solutions that will enhance patient care and provide incremental productivity," said Richard Linden, President and CEO. "Our modular, scalable solution assures that NHS Healthcare Trusts of any size or configuration can have a workable solution that fits their needs exactly. And as importantly, they will have an experienced, trusted UK-based service and support team through our partner - TPS Medical."

"We are pleased to be partnering with Merge eFilm because of their sixteen year history of PACS integration expertise," said David Lawrence, Managing Director of TPS Medical. "The depth of their experience in DICOM, IHE and PACS integration is crucially important to the NHS Trust hospitals, where the integration of legacy modalities and disparate IT systems are crucial to successful workflow. We have worked with Merge eFilm in the successful installation of over twenty Scottish hospitals of varied sizes and multiple configurations, and their level of expertise and experience has been a key component of our success in Scotland. We are looking forward to replicating our successes across the UK."

***

Merge eFilm provides integrated healthcare image and information workflow solutions that create a filmless workflow environment, address the clinical imaging needs across the healthcare enterprise, and enable cost-effective, patient-centric care. For more than sixteen years, Merge eFilm has leveraged its healthcare IT, clinical and engineering experience to create elegant and affordable solutions that improve the clinicians' productivity and enhance the quality of the care they provide.

TPS Medical is a healthcare solutions provider that works with UK hospitals to enhance their operational systems and improve the cost-effectiveness their patient care.

For more information about the Merge eFilm and TPS Medical, go to www.merge-efilm.co.uk.

Press Contact
Attn: Beth Frost-Johnson Merge Healthcare 6737 West Washington St. Suite 2250 Milwaukee, WI 53214		Phone: 1-(414) 977-4254
Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.